SCHEMBL22062742

SCHEMBL22062742

c1ccc2c(c1)nc1n2c2cccc3c2n1c1nc2c4ccccc4c4ccccc4c2n31

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
MAPT P10636 5/20 0.38
LMNA P02545 3/20 0.38
TP53 P04637 2/20 0.38
POLB P06746 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 5/20 0.37
ALDH1A1 P00352 5/20 0.37
KMT2A Q03164 6/20 0.35
MEN1 O00255 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
FLT3 P36888 1/20 0.33
BMX P51813 1/20 0.33
BCL2 P10415 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
GAA P10253 1/20 0.33
NPC1 O15118 2/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22063269 0.91 MAPT (0.37) KDM4EMAPTLMNATP53POLB
SCHEMBL22063142 0.86 KDM4E (0.34) KDM4ELMNAALDH1A1
SCHEMBL22063249 0.85 KDM4E (0.36) KDM4ELMNATP53HPGDALDH1A1
SCHEMBL24495866 0.84 KDM4E (0.41) KDM4EMAPTLMNATP53POLB
SCHEMBL22062740 0.84 KDM4E (0.41) KDM4EMAPTLMNATP53POLB
SCHEMBL22062588 0.83 TLR8 (0.33) MAPTLMNAHSD17B10HPGDALDH1A1
SCHEMBL14868036 0.83 KDM4E (0.42) KDM4EMAPTLMNATP53POLB
SCHEMBL22062730 0.81 KDM4E (0.37) KDM4EMAPTLMNATP53POLB
SCHEMBL20547116 0.81 KDM4E (0.44) KDM4EMAPTLMNATP53POLB
SCHEMBL13852979 0.80 MAPT (0.44) KDM4EMAPTLMNATP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EMC2, NFE2L2, AOC2 KDM4E 1152/4885MAPT 2667/4885LMNA 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.